HCPCS Level IIdrugActive
J0742
Inj imip 4 cilas 4 releb 2mg
BETOS: O1E
Effective: 2020-07-01
Description
Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Recarbrio
Manufacturer
Merck Sharp & Dohme LLC
HCPCS Dosage
4 MG-4 MG-2 MG
Billing Units
125.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.